| Identification |
| Name: | Benzenepropanamide,N-[6-[[2-[(3'R,3'aS,6'S,6aS,6bS,7'aR,2'R,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-3-oxospiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-4'-yl]ethyl]amino]-6-oxohexyl]- |
| Synonyms: | KAAD-cyclopamine |
| CAS: | 306387-90-6 |
| Molecular Formula: | C44H63 N3 O4 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C44H63N3O4/c1-29-25-39-42(47(28-29)24-23-46-40(49)13-9-6-10-22-45-41(50)17-14-32-11-7-5-8-12-32)31(3)44(51-39)21-19-35-36-16-15-33-26-34(48)18-20-43(33,4)38(36)27-37(35)30(44)2/h5,7-8,11-12,15,29,31,35-36,38-39,42H,6,9-10,13-14,16-28H2,1-4H3,(H,45,50)(H,46,49)/t29?,31-,35?,36?,38?,39-,42?,43?,44?/m1/s1 |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 483.3°C |
| Boiling Point: | 875.6°C at 760 mmHg |
| Density: | 1.15g/cm3 |
| Refractive index: | 1.588 |
| Flash Point: | 483.3°C |
| Usage: | Cyclopamine demonstrates teratogenic properties and has been shown to reverse effects ofoncogenic mutations in Smoothened and Patched.1 The KAAD derivative has shown 10-20 fold higher potency than cyclopamine in inhibition of ?Galactosidase expres |
| Safety Data |
| |
 |
